Genmab A/S (GNMSF) Stock Chart & Stock Price History $221.78 -1.32 (-0.59%) As of 02/21/2025 02:09 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Genmab A/S Stock Price Performance 5 Day Performance+5.12%1 Month Performance+5.76%3 Month Performance+10.89%6 Month Performance-17.44%Year-To-Date Performance+6.94%1 Year Performance-22.89% Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address GNMSF Stock Chart for Saturday, February, 22, 2025 GNMSF Chart by TradingView Genmab A/S Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$223.10$221.78-0.59%$223.45$220.8823 shs$14.65 billion02/20/2025$218.06$223.10+2.31%$224.04$222.7399 shs$14.74 billion02/19/2025$216.14$218.06+0.89%$219.06$217.5934 shs$14.41 billion02/18/2025$210.97$216.14+2.45%$216.59$214.71512 shs$14.28 billion02/17/2025$210.97$210.97$212.48$210.30157 shs$13.94 billion02/14/2025$207.62$210.97+1.61%$212.48$210.30157 shs$13.94 billion02/13/2025$191.84$207.62+8.23%$207.62$200.7330 shs$13.72 billion02/12/2025$186.76$191.84+2.72%$191.84$191.8411 shs$12.67 billion02/11/2025$186.61$186.76+0.08%$190.77$186.7686 shs$12.34 billion02/10/2025$187.73$186.61-0.60%$188.99$186.6126 shs$12.33 billion Get the Latest News and Ratings for GNMSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$192.17$187.73-2.31%$189.07$187.737,644 shs$12.40 billion02/06/2025$193.11$192.17-0.48%$193.26$191.439,946 shs$12.70 billion02/05/2025$191.40$193.11+0.89%$194.95$192.9329 shs$12.76 billion02/04/2025$190.15$191.40+0.66%$191.40$191.401 shs$12.65 billion02/03/2025$197.44$190.15-3.69%$192.83$190.15717 shs$12.56 billion01/31/2025$197.87$197.44-0.22%$198.49$197.4430 shs$13.05 billion01/30/2025$195.64$197.87+1.14%$197.87$194.54233 shs$13.07 billion01/29/2025$194.00$195.64+0.85%$197.31$192.95187 shs$12.93 billion01/28/2025$208.35$194.00-6.89%$194.00$190.47107,092 shs$12.82 billion01/27/2025$207.90$208.35+0.22%$216.17$208.261,185 shs$13.77 billion01/24/2025$207.54$207.90+0.17%$215.50$207.50543 shs$13.74 billion01/23/2025$209.70$207.54-1.03%$214.26$207.54859 shs$13.71 billion01/22/2025$214.89$209.70-2.42%$217.02$209.70391 shs$13.85 billion01/21/2025$207.44$214.89+3.59%$217.40$213.884,785 shs$14.20 billion Related Companies Daiichi Sankyo Stock Chart Takeda Pharmaceutical Stock Chart argenx Stock Chart BioNTech Stock Chart Beigene Stock Chart Teva Pharmaceutical Industries Stock Chart Summit Therapeutics Stock Chart Genmab A/S Stock Chart Moderna Stock Chart Intra-Cellular Therapies Stock Chart Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GNMSF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
